Cargando…
Serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patients with gastric cancer
The importance of tumour angiogenesis in the process of tumour growth and progression in solid tumours has been widely accepted. Among many angiogenic factors, vascular endothelial growth factor (VEGF) has been shown to play a major role in the development and dissemination of the malignant tumours....
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363092/ https://www.ncbi.nlm.nih.gov/pubmed/10408410 http://dx.doi.org/10.1038/sj.bjc.6690573 |
_version_ | 1782153618007261184 |
---|---|
author | Eroğlu, A Demirci, S Ayyildiz, A Kocaoğlu, H Akbulut, H Akgül, H Elhan, H A |
author_facet | Eroğlu, A Demirci, S Ayyildiz, A Kocaoğlu, H Akbulut, H Akgül, H Elhan, H A |
author_sort | Eroğlu, A |
collection | PubMed |
description | The importance of tumour angiogenesis in the process of tumour growth and progression in solid tumours has been widely accepted. Among many angiogenic factors, vascular endothelial growth factor (VEGF) has been shown to play a major role in the development and dissemination of the malignant tumours. Nitric oxide (NO) production was also observed in solid tumour tissues. NO has been reported to play an important role for the mitogenic effect of VEGF in the angiogenic process. However, little is known about the correlation between VEGF and NO in circulating levels. Therefore, we investigated serum VEGF and NO concentrations in human gastric cancers as well as healthy individuals, and examined the influence of tumour stage on circulating level of VEGF. The study consisted of 11 healthy individuals and 37 patients with primary gastric cancer who did not receive any prior therapy. Patients were categorized into four groups according to TNM classification. The level of VEGF(165) in preoperative sera of gastric cancer patients and healthy donors was assayed using the quantitative sandwich enzyme immunoassay technique. NO concentration was estimated indirectly from serum nitrite. The ANOVA test showed a significant difference in serum VEGF(165) concentrations between tumour stages (P < 0.001). A striking relationship was found between serum NO levels and tumour stage (P < 0.001). A significant difference was also seen between healthy individuals and patients with stage 1 disease. The present study suggested that large tumour burden was associated with significantly increased levels of VEGF(165) and NO. © 1999 Cancer Research Campaign |
format | Text |
id | pubmed-2363092 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1999 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23630922009-09-10 Serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patients with gastric cancer Eroğlu, A Demirci, S Ayyildiz, A Kocaoğlu, H Akbulut, H Akgül, H Elhan, H A Br J Cancer Regular Article The importance of tumour angiogenesis in the process of tumour growth and progression in solid tumours has been widely accepted. Among many angiogenic factors, vascular endothelial growth factor (VEGF) has been shown to play a major role in the development and dissemination of the malignant tumours. Nitric oxide (NO) production was also observed in solid tumour tissues. NO has been reported to play an important role for the mitogenic effect of VEGF in the angiogenic process. However, little is known about the correlation between VEGF and NO in circulating levels. Therefore, we investigated serum VEGF and NO concentrations in human gastric cancers as well as healthy individuals, and examined the influence of tumour stage on circulating level of VEGF. The study consisted of 11 healthy individuals and 37 patients with primary gastric cancer who did not receive any prior therapy. Patients were categorized into four groups according to TNM classification. The level of VEGF(165) in preoperative sera of gastric cancer patients and healthy donors was assayed using the quantitative sandwich enzyme immunoassay technique. NO concentration was estimated indirectly from serum nitrite. The ANOVA test showed a significant difference in serum VEGF(165) concentrations between tumour stages (P < 0.001). A striking relationship was found between serum NO levels and tumour stage (P < 0.001). A significant difference was also seen between healthy individuals and patients with stage 1 disease. The present study suggested that large tumour burden was associated with significantly increased levels of VEGF(165) and NO. © 1999 Cancer Research Campaign Nature Publishing Group 1999-07 /pmc/articles/PMC2363092/ /pubmed/10408410 http://dx.doi.org/10.1038/sj.bjc.6690573 Text en Copyright © 1999 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Regular Article Eroğlu, A Demirci, S Ayyildiz, A Kocaoğlu, H Akbulut, H Akgül, H Elhan, H A Serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patients with gastric cancer |
title | Serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patients with gastric cancer |
title_full | Serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patients with gastric cancer |
title_fullStr | Serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patients with gastric cancer |
title_full_unstemmed | Serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patients with gastric cancer |
title_short | Serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patients with gastric cancer |
title_sort | serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patients with gastric cancer |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363092/ https://www.ncbi.nlm.nih.gov/pubmed/10408410 http://dx.doi.org/10.1038/sj.bjc.6690573 |
work_keys_str_mv | AT eroglua serumconcentrationsofvascularendothelialgrowthfactorandnitriteasanestimateofinvivonitricoxideinpatientswithgastriccancer AT demircis serumconcentrationsofvascularendothelialgrowthfactorandnitriteasanestimateofinvivonitricoxideinpatientswithgastriccancer AT ayyildiza serumconcentrationsofvascularendothelialgrowthfactorandnitriteasanestimateofinvivonitricoxideinpatientswithgastriccancer AT kocaogluh serumconcentrationsofvascularendothelialgrowthfactorandnitriteasanestimateofinvivonitricoxideinpatientswithgastriccancer AT akbuluth serumconcentrationsofvascularendothelialgrowthfactorandnitriteasanestimateofinvivonitricoxideinpatientswithgastriccancer AT akgulh serumconcentrationsofvascularendothelialgrowthfactorandnitriteasanestimateofinvivonitricoxideinpatientswithgastriccancer AT elhanha serumconcentrationsofvascularendothelialgrowthfactorandnitriteasanestimateofinvivonitricoxideinpatientswithgastriccancer |